Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
- PMID: 32382744
- PMCID: PMC7239106
- DOI: 10.1093/ibd/izaa114
Anti-TNF-α Agents in Inflammatory Bowel Disease and Course of COVID-19
Comment in
-
Inflammatory Bowel Disease and COVID-19-"Preventive" Sick Certificates as a Frequent Coping Strategy in the Face of the Pandemic.Inflamm Bowel Dis. 2020 Aug 20;26(9):e105-e106. doi: 10.1093/ibd/izaa155. Inflamm Bowel Dis. 2020. PMID: 32530027 Free PMC article. No abstract available.
Comment on
-
Challenges in the Care of IBD Patients During the CoViD-19 Pandemic: Report From a "Red Zone" Area in Northern Italy.Inflamm Bowel Dis. 2020 May 12;26(6):793-796. doi: 10.1093/ibd/izaa084. Inflamm Bowel Dis. 2020. PMID: 32314792 Free PMC article. No abstract available.
References
-
- Brenner EJ, Ungaro RC, Colombel JF, et al. . SECURE-IBD Database Public Data Update www.covidibd.org. Accessed April 21, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
